Together, Boehringer Ingelheim and Roche will leverage complementary expertise and innovative LNA technology to bring novel treatment approaches to IBD patients. Source: BioSpace

A little less than two years after tying up a multi-billion deal with Sanofi, DiCE Molecules scored another collaborative deal. Source: BioSpace

Should you invest the way billionaire investors do? Source: BioSpace

The fact that Roche has separate R&D units has been the topic of second-guessing on the part of observers and analysts. Source: BioSpace

Array BioPharma announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations. Source: BioSpace

The round was co-led by funds managed by new investor Janus Henderson Investors. Source: BioSpace

Under terms of the deal, Boehringer has the option to acquire Autifony's Kv3.1/3.2 positive modulator platform, which includes the company's lead compound AUT00206. Source: BioSpace

Now that we've got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months.…

Dr. Ryan becomes a Director of the Company effective immediately and will assume his responsibilities as CEO effective February 15, 2018. Source: BioSpace

The round was led by Bain Capital Life Sciences. Source: BioSpace